Michael Thomas Henderson is CEO at Apogee Therapeutics, Inc. (APGE). They have made 16 open-market trades across 2 companies since 2019, most recently 2026-07-10.
CIK 0001779990
1 open-market purchase totalling $119K since 2019, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APGE | 920,941 | $124.4M |
| BBIO | 261,399 | $17.4M |
| SYRE | 68,606 | $5.5M |
| Total | $147.2M |
Shares reported on the most recent Form 4, priced at the 2026-07-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APGE | SELL · 10b5-1 | 2026-07-08 | 2026-07-10 | $133.63 | $2.7M | +0.3% | +0.8% | — |
| SYRE | SELL · 10b5-1 | 2026-06-22 | 2026-06-23 | $100.00 | $2.0M | +5.9% | +19.4% | +9.8% |
| APGE | SELL · 10b5-1 | 2026-06-22 | 2026-06-24 | $132.54 | $10.6M | +0.5% | +1.1% | N/A |
| APGE | SELL · 10b5-1 | 2026-06-10 | 2026-06-12 | $83.38 | $1.7M | +50.7% | +52.0% | N/A |
| APGE | SELL · 10b5-1 | 2026-05-13 | 2026-05-15 | $82.09 | $1.6M | -4.8% | +5.3% | +64.3% |
| SYRE | SELL · 10b5-1 | 2026-05-08 | 2026-05-08 | $74.40 | $6.0M | -4.2% | -4.2% | +37.6% |
| APGE | SELL · 10b5-1 | 2026-04-08 | 2026-04-10 | $82.58 | $1.7M | +5.2% | -1.9% | +55.0% |
| APGE | SELL | 2026-03-11 | 2026-03-13 | $74.78 | $1.5M | +9.1% | +20.5% | +24.3% |
| APGE | SELL · 10b5-1 | 2026-02-11 | 2026-02-13 | $63.35 | $1.3M | +2.3% | +5.3% | +24.2% |
| APGE | SELL | 2026-01-14 | 2026-01-16 | $81.11 | $1.6M | -11.4% | -11.8% | +14.7% |
| APGE | SELL · 10b5-1 | 2025-12-10 | 2025-12-12 | $75.37 | $3.0M | +0.5% | -0.1% | -5.4% |
| APGE | SELL · 10b5-1 | 2025-12-04 | 2025-12-05 | $75.01 | $3.0M | -0.7% | +2.0% | -6.7% |
| APGE | SELL · 10b5-1 | 2025-11-13 | 2025-11-13 | $63.01 | $2.5M | +16.0% | +25.6% | +7.6% |
| APGE | SELL · 10b5-1 | 2025-03-05 | 2025-03-07 | $30.15 | $603K | +13.9% | -9.0% | +6.0% |
| APGE | SELL · 10b5-1 | 2025-02-05 | 2025-02-07 | $40.58 | $609K | -14.8% | -5.8% | -5.1% |
| APGE | SELL · 10b5-1 | 2025-01-08 | 2025-01-10 | $48.85 | $1.5M | -1.9% | -4.0% | -27.0% |
| APGE | SELL · 10b5-1 | 2024-12-04 | 2024-12-06 | $46.64 | $778K | -10.3% | -3.1% | -28.9% |
| APGE | SELL · 10b5-1 | 2024-11-06 | 2024-11-08 | $59.22 | $888K | -29.1% | -22.7% | -34.4% |
| APGE | SELL · 10b5-1 | 2024-10-02 | 2024-10-04 | $56.23 | $4.5M | +4.9% | +3.9% | -13.0% |
| APGE | SELL · 10b5-1 | 2024-09-04 | 2024-09-06 | $47.62 | $3.8M | +12.4% | +16.4% | -0.6% |
| APGE | SELL · 10b5-1 | 2024-08-07 | 2024-08-09 | $40.62 | $3.2M | +20.9% | +18.8% | +45.2% |
| APGE | SELL · 10b5-1 | 2024-07-05 | 2024-07-05 | $37.26 | $559K | +27.7% | +6.2% | +47.5% |
| BBIO | SELL | 2020-12-01 | 2020-12-02 | $51.52 | $1.0M | +24.7% | +29.7% | +34.9% |
| BBIO | SELL | 2020-11-16 | 2020-11-18 | $45.00 | $450K | +18.9% | +51.1% | +51.1% |
| BBIO | SELL | 2020-11-02 | 2020-11-03 | $38.36 | $384K | +9.2% | +26.8% | +44.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.